Loading
Kronox Lab Sciences Stock: price and insider trades · India
IN·Mcap ₹8B
Kronox Lab Sciences: what insiders have been doing
Kronox Lab Sciences is a listed company. Its directors and officers file their transactions with SEBI (PIT + SAST). Between 18 October 2025 and 18 October 2026, 7 insiders published 8 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 1,987 companies) published 4 filings over the same period, against 8 filings here.
No insider has bought Kronox Lab Sciences shares on the open market in the past twelve months. Publication is fast: at least half of the trades appear on SEBI (PIT + SAST) on the same day. This delay matters because a trade only becomes useful information once it is public.
Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Insider Decl.
8
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,405 of 24,166 companies
65.5
score / 100
Value44
Quality87
FCF yld2.6%
Earn yld3.5%
EV/EBITDA19.8x
ROE·
Gross mgn54%
Net mgn27%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹216.00
Analyst consensus
Income statement
Revenue₹1B
Gross profit₹546.4M54% margin
EBITDA₹394.6M39% margin
Net income₹276.6M27.2% margin
Valuation
PER (trailing)28.6x
P/Book6.8x
Beta0.89
Balance sheet & cash
Market cap₹8B
Total debt₹16.1M
Free Cash Flow₹205.9M
Debt / Equity1%
Profitability & ownership
% insiders11.7%
% institutions0.0%
Last declaration on 1 October 2026
Declarations8 total
8,566,400 shares@ ₹103.20100.0% of flowEquityOthersSEBI:f0756c9522d6b844f2679a2bf3fd4fbe21691c5b
8,566,400 shares@ ₹103.20100.0% of flowEquityOthersSEBI:688aabd9ac6a857c60d31e9416b4e5f7914b4bdf
6,711,200 shares@ ₹103.20100.0% of flowEquityOthersSEBI:12357e14e90a03798602525473e44121654e257d
8,566,400 sharesEquity SharesSale of Shares - offmarketSEBI:c9ab1f9c2bb34f286a889282a68ac0ef2fd84347
6,711,200 sharesEquity SharesAcquisition of shares - offmarketSEBI:3a7ced96bc1ab27fe93c35905eb928e0be939d99
8,566,400 sharesEquity SharesAcquisition of shares - offmarketSEBI:3451d4484c9b066b5f4558c81bdeaf359290e7f2
8,566,400 sharesEquity SharesSale of Shares - offmarketSEBI:4c536f389a77da63811cc6f01a182cec901fc5d7
6,711,200 sharesEquity SharesSale of Shares - offmarketSEBI:780b27d00e8e538a6a306dd0362d68ed38c73bb4
8 of 8 declarations
About Kronox Lab Sciences
Kronox Lab Sciences is a company specializing in laboratory sciences, providing innovative solutions for the healthcare sector. It operates in the XBOM market.
